Skip to content

Thrombembolism After Robot- Assisted Surgery in Urology

Postoperative Arterial or Venous Thrombembolism After Robot- Assisted Surgery in Major Urological Procedures is in Some Cases a Severe Complication.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04796740
Enrollment
450
Registered
2021-03-15
Start date
2019-12-17
Completion date
2021-12-31
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Embolism, Surgery--Complications, Thrombosis, Urologic Cancer

Keywords

thrombembolism after robot-assisted surgery

Brief summary

Cancer patients have an increased risk of perioperative complications undergoing surgery procedures. Postoperative complications caused by thrombembolic events after robot- assisted surgery in major urological procedures have been reported and associated with an increased lenght of stay in the hospital. We therefore aimed to investigate in a retrospective analysis 250 patients undergoing robotic-assisted radical cystectomy and prostatectomy procedures for risk factors for thrombembolic events in this specific patient population.

Detailed description

Postoperative arterial or venous thrombembolism after robotic- assisted surgery in major urological procedures are reported severe complications in this patient population. After having studied the available literature on this particular topic the investigators have decided to prepare a retrospective analysis of approximately 250 robot- assisted radical cystectomy and radical prostatectomy surgical procedures. In due consideration of perioperative prophylaxis of thrombembolic Events we determine the clinical and radiological signs of venous or arterial thrombembolism postoperatively with a particular focus on early postoperative pulmonary embolism events. This is a retrospective analysis of 250 robotic-assisted radical cystectomy and radical prostatectomy surgical procedures.

Interventions

None listed

Sponsors

University Hospital Schleswig-Holstein
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* over 18 years of age * scheduled for urological surgery (cystectomy and/or prostatectomy) * signed basical declaration of consent

Exclusion criteria

* absent or unsigned basical declaration of consent

Design outcomes

Primary

MeasureTime frameDescription
postoperative thrombembolismthrough study completion, an average of 1 yearArterial and venous thrombembolism after surgery

Secondary

MeasureTime frameDescription
pulmonary oedemathrough study completion, an average of 1 yearpulmonary oedema
pneumoniathrough study completion, an average of 1 yearpneumonia
wound infectionthrough study completion, an average of 1 yearwound infection
acute renal failurethrough study completion, an average of 1 yearacute renal failure
ocular complicationsthrough study completion, an average of 1 yearocular complications
deliriumthrough study completion, an average of 1 yeardelirium
Major adverse cardiovascular events (MACE)through study completion, an average of 1 yearnonfatal stroke, nonfatal myocardial infarction and cardiovascular death

Countries

Germany

Contacts

Primary ContactJochen Renner, Prof. Dr.
jochen.renner@uksh.de004943150020801
Backup ContactUlf Lorenzen, Dr.
ulf.lorenzen@uksh.de004943150020801

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026